Anika Therapeutics (ANIK) Q2 Earnings Lag Estimates

Anika Therapeutics (ANIK) came out with quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.23 per share. This compares to loss of $0.19 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -26.09%. A quarter ago, it was expected that this medical technology company would post a loss of $0.19 per share when it actually produced a loss of $0.31, delivering a surprise of -63.16%.Over the last four quarte ...